Home | Back to newsletter main page
| |
 |
|
December 17, 2012 |
|
CASE CCC IN THE NEWSCWRU School of Medicine Researchers Discover New Molecule Linked to Late-stage Breast Cancer New Study Finds 'Hidden' Cancer Cells, Personalized Care Still a Challenge Pre-Transplant Umbilical Cord Blood Expansion in Lab Speeds Establishment of New Blood Supply in Patients, Reducing High-Risk Time to Recovery Child Cured of Leukemia With Breakthrough Treatment Axitinib Fails to Meet Primary Endpoint in Treatment-Naive RCC ANNOUNCEMENTSDr. Noa Noy Receives NCI R01
Obtaining Human Tissues for Cancer ResearchThe Case CCC wishes to make its members aware that a Data Use Agreement has been approved by the University Hospitals Legal Affairs Office. This Data Use Agreement will greatly facilitate obtaining tissue for cancer research in situations where protected health information is not necessary for the research. A wide variety of tissues is available from the Tissue Resources Core, and samples from the hospital's clinical archives of paraffin-embedded tissues may also be obtained. You are encouraged to visit the Tissue Resources website for information about available biospecimens. Application forms are accessible from the Case CCC Tissue Resources page, and from the Clinical Research Office page. Use the Tissue Research Application for studies that involve research activities limited to archived or discarded tissue. Contact David Goldblatt at 216.844.5060, david.goldblatt@case.edu and/or Kristin Waite at 216.844.5537, kristin.waite@case.edu for guidance on the application process. FUNDING OPPORTUNITIES/AWARDSAmerican Association for Cancer ResearchThe American Association for Cancer Research (AACR) is currently accepting applications for the following funding opportunities for individual researchers:
Sarcoma Foundation of AmericaThe Sarcoma Foundation of America has developed a program to provide grants to investigators interested in translational science Sarcoma research. Funding is available to cover equipment and supplies in support of research on the etiology, molecular biology, pathogenesis, diagnosis, and treatment of human Sarcomas. In accordance with the mission of the Foundation, research involving the development of novel agents against Sarcoma, or research that could potentially lead to the development of novel agents against Sarcoma, is eligible for this funding. The SFA strongly prefers – and will give special consideration to – applications that focus on the following areas of research:
Deadline: January 31, 2013 Avon Foundation 2013 Breast Cancer Research ProgramThe 2013 Avon Foundation Research Program seeks proposals to advance understanding of causes of breast cancer and prevention. The Foundation seeks to develop new strategies to prevent breast cancer by understanding the causes of breast cancer in people, changes in breast cells that give rise to cancer, markers for disease, and how breast cancer progresses. LOI Deadline: February 4, 2013 Childhood Brain Tumor Foundation Research GrantsThe Childhood Brain Tumor Foundation (CBTF) is soliciting grant applications for the calendar year 2013 in the following categories: Pediatric Brain Tumor Grant Awards and Pilocytic Astrocytoma Award. Grants are evaluated in the context of their potential to:
Deadline: March 12, 2013 | EVENTS
December 17Cancer Center Research Chalk Talk Skeletal Research Center Seminar Cell Death Regulation Program Meeting December 18Hematology and Oncology Special Research Conference Cancer Biology Fellow Seminar Medicine Grand Rounds December 19Hematology and Oncology Division Research Conference canceled December 20Cancer Trainee Seminar Cancer Center Special Seminar December 21Cancer Center Research in Progress canceled Cancer Center Seminar Series canceled Taussig Cancer Institute Grand Rounds canceled Hematology/Oncology Fellows Conference/Curriculum Series
UPCOMING CANCER CENTER SYMPOSIUMS & EVENTS16th Annual Meeting of the Translational Research Cancer Centers Consortium (TRC3): The Power of Negative Thinking: Inhibiting the Inhibitors of Tumor Immunity
ADDITIONAL UPCOMING SEMINARS & EVENTSPacific Symposium on Biocomputing 2013 |
|
|
|
NCI CANCER BULLETINDecember 11, 2012News In Depth Updates |
|
|
|
|
PREVIOUSLY ANNOUNCED OPPORTUNITIES |
|
|
Alex's Lemonade Stand Foundation Epidemiology Awards |
Prostate Cancer Foundation 2013 Young Investigator Awards |
|
|
|
NIH BULLETIN – Notices and Funding OpportunitiesAIDS and Cancer Specimen Resource (ACSR) (UM1)(RFA-CA-13-005) Collaborative Activities to Promote Metabolomics Research (Admin Supp)(PA-13-041) AHRQ Mentored Clinical Scientist Research Career Development Award (K08)(PA-13-039) |
|
| Produced by: Gillian Irwin Todd 11100 Euclid Avenue, Wearn 149 Cleveland, Ohio 44106-5065 216.844.8317 phone 216.844.7832 fax gillian.irwin@case.edu |
HELP US HELP YOU!If you have a new grant, recently won an award, or have other newsworthy items, please let us know so we can publicize them in the newsletter and other media outlets. You deserve the accolades! Send items to gillian.irwin@case.edu. |
|
|
Dr. Noa Noy recently received an R01 from the NCI for her project, Retinoic Acid and CRABP-II in Regulation of Post Transcriptional Gene Silencing. The proposed studies are designed to explore the possibility that anticarcinogenic activities of CRABP-II and RA are mediated in part through their involvement in regulating mRNA stability. The studies aim to investigate the molecular basis for the cooperation of CRABP-II with HuR in stabilizing mRNA, and to explore the involvement of this cooperation in mammary carcinoma biology. At the level of basic science, the results of these studies will provide important insights into a previously unsuspected non-genomic function of RA as well as into a novel mechanism for regulating transcript stability in cells. The findings of this work may also point at a novel target for therapeutic approaches in cancer treatment.